Analysis of Drugs Antihelmintic Properties in the Pharmaceutical Market of Uzbekistan

Radjapova Nozima Shavkatovna; Karieva Ekut Saidkarimovna Karieva Ekut Saidkarimovna2; Khamdamov Mirzabotir Mirzaxaydarovich

Radjapova Nozima Shavkatovna Tashkent Pharmaceutical Institute
Karieva Ekut Saidkarimovna Tashkent Pharmaceutical Institute
Khamdamov Mirzabotir Mirzaxaydarovich Tashkent Pharmaceutical Institute

Keywords: marketing research, antihelmintic drugs, State Register, drug form, country of manufacture, nature of active substance.

Abstract

The article presents the results of the analysis of drugs with antihelmintic properties in the domestic pharmaceutical market. The object of research was the State Register of drugs, medical equipment and medical equipment approved for use in medical practice in the Republic of Uzbekistan. As a result of the analysis, the total number of registered drugs of this pharmacotherapeutic group was calculated, and conclusions were drawn on the share of producing countries, the form of the drug, and the nature of the active substance. Based on the results of the research, among the antihelmintic drugs registered in the Republic of Uzbekistan, the first place in terms of share is taken by the drugs produced in Uzbekistan, the second place by the drugs of foreign countries, and the third place by the drugs of the CIS countries. It was found that the average share of herbal medicines in the analyzed period among all mentioned medicines is 17.2%, the share of synthetic drugs is 76.2%, and the share of combined drugs is 6.6%. According to the form of the drug, it was found that antihelminth drugs are mainly produced in the form of a solid drug that is easy to drink and stable in storage. However, from 2019 to 2023, the share of drugs derived from plant raw materials and belonging to this pharmacotherapeutic group will decrease and the number of synthetic drugs will increase. Taking into account a number of side effects of synthetic drugs, the production and introduction of effective, stable and high-quality drugs with antihelmintic properties based on local plant raw materials has been proved to be relevant.

References

Bronstein A.M., Malyshev N.A. Human helminthiases. Moscow, 2010. 109 p.
Askerko A.Ch. Fundamentals of parasitology.-Minsk.-2008.-140 p.
Petrovsky A.V. Parasitology.-Minsk.-2007.-354 p..
Tokmalaev A.K. Human helminthiases: clinical and pathogenetic features, current state of diagnostics and treatment // Attending physician.-2009.-№7.
Lysenko A.Ya., Vladimova M.G., Kondrashin A.V., Maiori J. Clinical Parasitology: Manual.-Geneva: WHO, 2002.-752 p.
Mochalova A.A., Ershova I.B. A look at the problem of helminthiasis and parasitosis at the present stage // Actual infectology.-2014.-№ 2 (3).-P.61-64.
Farhadov G.T. Anthelmintic effect of sainfoin (Onobrychis vicifolia Scop.) and alfalfa (Medicago sativa L.) in sheep // Bulletin of V.N. Karazin Kharkiv National University.-2015.-№25.-P. 341-344.
Pozdeeva M.A., Saltykova Ya.A., Filimonova E.A. Helminthiases most frequently registered in the Arkhangelsk region // Universum: Medicine and Pharmacology.-2022.-No. 6 (89).-P. 9-11.
Bayekeeva K.T., Sadykova A.M., Seidullaeva L.B., Umeshova L.A., Imailova B.S. Ubiquitous helminthiases //Bulletin of KazNMU.-2017.-No.1.-P.101-108.
Karomatova I.D., Davlatova M.S. Medicinal plants with anthelmintic and antiechinococcosis activity // Biology and integrative medicine.-2018.-№11.-P.116-130.
Al Jomaa R., Maksimov M.L., Streljaeva A.V., Sadykov V.M., Vakhidova A.M. New preparations from plant materials for the treatment of helminthiasis in animals // Veterinary doctor. - 2015. - No. 5. - P. 14-19.
Bekezhanova T.S., Sakipova Z.B., Ibragimova L.N., Zhakipbekov K.S., Tulemisov S.K., Nurbayuly A. Pharmaceutical development of anthelmintic tablets "Artegon" // Bulletin of Pharmacy. - 2018.-No. 1 (79).-P.58-64.
Rudneva O.V. Use of the drug cina in trichinellosis on a laboratory model // Theory and practice of combating parasitic diseases.-2017.-№18.-P.397-398.
Beshay E.V.N. Therapeutic efficacy of Artemisia absinthium against Hymenolepis nana: in vitro and in vivo studies in comparison with the anthelmintic praziquantel //J. Helminthol.-2018.-Vol.92(3).-P.298-308. doi: 10.1017/S0022149X17000529.
Hajaji S., Alimi D., Jabri M.A., Abuseir S., Gharbi M., Akkari H. Anthelmintic activity of Tunisian chamomile (Matricaria recutita L.) against Haemonchus contortus //J. Helminthol.-2018/-Vol. 92(2).-P.168-177. doi: 10.1017/S0022149X17000396.
State Register of Medicines, Medical Devices and Medical Equipment Approved for Use in Medical Practice. - 23rd ed. - T.: Komron press LLC, 2019. - 712 p.
State Register of Medicines, Medical Devices and Medical Equipment Approved for Use in Medical Practice. - 24th ed. - T.: Komron press LLC, 2020. - 776 p.
State Register of Medicines, Medical Devices and Medical Equipment Approved for Use in Medical Practice. - 25th ed. - T.: Komron press LLC, 2021. - 937 p.
State Register of Medicines, Medical Devices and Medical Equipment. - 2022. - 26th ed. (electronic resource: www.uzpharm-control.uz/ru/pages/state-register-of-medicines-and-medical-products).
State Register of Medicines, Medical Devices and Medical Equipment.-2023.-27th ed. (electronic resource: www.uzpharm-control.uz/ru/pages/state-register-of-medicines-and-medical-products).